While the company is in discussions to acquire SpringWorks, it did not elaborate on these talks in its earnings call.

Q4 2024 Results Conference Call March 6, 2025 8:00 AM ETCompany ParticipantsFlorian Schraeder - Head of Investor ...

Germany's Merck KGaA expects earnings and sales growth this year after reporting a rise in annual earnings on temporarily reduced research and development expenses in its healthcare segment and strict ...

A SeQuant ZIC-pHILIC (2.1 × 100 mm, 5-μm particle) column (Merck KGaA, Darmstadt, Germany ... Columns represent individual samples; rows represent each metabolite. Figure 5. Chart of the top 25 SMPDB ...

Merck shares have been under pressure amid disappointing sales trends for its Gardasil HPV vaccine. The company's broader drug portfolio continues to perform well and is driving a strong earnings ...

→ Pe­ter Guenter will re­tire as CEO of Mer­ck KGaA’s health­care busi­ness on June 1, one of sev­er­al per­son­nel moves that the Ger­man phar­ma … ...

Following an increase in attention after Kendrick’s performance of the diss track at his Super Bowl LIX halftime show, Not Like Us re-entered the Official Singles Chart Top 10 at Number 2 last ...

No cruel intentions here: Merck KGaA’s U.S. pharma arm has recruited actor Selma Blair for a collaboration around multiple sclerosis treatment Mavenclad. Blair, best known for her roles in turn ...

Lawsuits surrounding Merck's HPV vaccine Gardasil have been piling up for years now, but they've garnered increased public attention lately after HHS Secretary Robert F. Kennedy Jr.'s links to the ...

Nuclear receptors regulate transcription in response to ligand signals and enable the pharmacological control of gene expression. However, many nuclear receptors are still poorly explored and are not ...

Merck & Co.’s first trial over the safety of its blockbuster Gardasil cancer vaccine was cut short and rescheduled amid concerns that jurors might be influenced by controversy this month around ...

E Merck KG's board of partners has announced the appointment of new CEOs to Merck KGaA’s executive board in a pivotal step in the company's ongoing growth strategy. Jean-Charles Wirth will ...